laryngeal cancer
laryngeal cancer  

     
   

Cyranose®,
The protection of the respiratory tract of the laryngectomy patient

Tracheoclean™,
easier post-operative care

Tracheodouche™,
protection in the shower

Amplicord®,
electro larynx

Notre offre : http://www.ceredas.com/gb/cyranose.htm
Documentation détaillée : Bibliographie

Since 1995, Ceredas designs, manufactures and distributes medical products designed for tracheotomy and laryngectomy patients.
A company entirely known under the double sign of innovation and quality, Ceredas is characterized by its goodwill of going further and further in order to improve the daily life of its patients.
After the artificial nose or HME Cyranose®, today an incontrovertible reference in terms of protection of the respiratory tracks of the laryngectomee, the company Ceredas then launched in 2005, the TracheocleanTM a disposable tracheal protection.
At the same time, Ceredas pursues actively a politic of improvement at international level.

Laryngeal cancer

The laryngeal cancer is a cancer usually developed at the level of vocal cords, in a part called the glottis. Like other cancers of the ENT, laryngeal cancer is what we call a squamous cell carcinoma in vast majority of cases.

Tobacco and alcohol are the two major risk factors. There are nearly 5000 new cases of laryngeal cancer each year in France and laryngeal cancer represents 25% of cancers in the upper aero digestive tract.

The treatment performed for laryngeal cancers can be a laryngectomy, which is a larynx removal requiring the completion of a definitive tracheotomy. The main consequence of this operation is a loss of natural voice, which becomes laryngeal.

The lack of filtration, heating and humidifying inspired air due to the intervention, can cause pulmonary complications such as cough, dry or tracheal hyper secretion.
The Cyranose® system, designed by Ceredas, responds effectively and permanently to the laryngectomy consequences; it humidifies and heats the air inspired, so that the breathe conditions are much more bearable for the patient.
Cyranose and other products features are all explained on www.ceredas.com.

Cancer laryngeal

The cancer laryngeal is a cancer usually developed at the level of vocal cords, in a part called the glottis. Like other cancers of the ENT, laryngeal cancer is what we call a squamous cell carcinoma in vast majority of cases.

Tobacco and alcohol are the two major risk factors. There are nearly 5000 new cases of cancer laryngeal each year in France and laryngeal cancer represents 25% of cancers in the upper aero digestive tract.

The treatment performed for laryngeal cancers can be a laryngectomy, which is a larynx removal requiring the completion of a definitive tracheotomy. The main consequence of this operation is a loss of natural voice, which becomes laryngeal.

The lack of filtration, heating and humidifying inspired air due to the intervention, can cause pulmonary complications such as cough, dry or tracheal hyper secretion.
The Cyranose® system, designed by Ceredas, responds effectively and permanently to the laryngectomy consequences; it humidifies and heats the air inspired, so that the breathe conditions are much more bearable for the patient.
Cyranose and other products features are all explained on www.ceredas.com.

Cancer of laryngeal

The cancer of laryngeal is a cancer usually developed at the level of vocal cords, in a part called the glottis. Like other cancers of the ENT, laryngeal cancer is what we call a squamous cell carcinoma in vast majority of cases.

Tobacco and alcohol are the two major risk factors. There are nearly 5000 new cases of cancer of laryngeal each year in France and laryngeal cancer represents 25% of cancers in the upper aero digestive tract.

The treatment performed for laryngeal cancers can be a laryngectomy, which is a larynx removal requiring the completion of a definitive tracheotomy. The main consequence of this operation is a loss of natural voice, which becomes laryngeal.

The lack of filtration, heating and humidifying inspired air due to the intervention, can cause pulmonary complications such as cough, dry or tracheal hyper secretion.
The Cyranose® system, designed by Ceredas, responds effectively and permanently to the laryngectomy consequences; it humidifies and heats the air inspired, so that the breathe conditions are much more bearable for the patient.
Cyranose and other products features are all explained on www.ceredas.com.

191, rue Adolphe Pajeaud • 92160 ANTONY • FRANCE
Tél. : +33 (0) 1 42 37 11 12 • Fax : +33 (0) 1 42 37 90 91

|
© Copyright 2001-2009 Ceredas
Laryngectomy | Laryngectomee | Laryngectomized | Laryngectomised | HME | Heat and Moisture Exchanger Artificial nose | Laryngeal cancer

Webmaster : attitude-graphique | Saisie avec Ingedata
Referencement naturel par Ingedata et référencement de site par eGate Référencement